# Liberate Bio

**Canonical:** https://apis.io/providers/liberatebio/  
**Website:** https://www.liberatebio.com/  
**APIs profiled:** 0

Liberate Bio is a genetic medicine company developing in vivo cell therapies that reach cell populations beyond the liver, the long-standing limit of lipid nanoparticle delivery. Its RAPTOR discovery platform is a scalable in vivo screening system that identifies LNP delivery vehicles which work with existing biology to carry genetic payloads into immune cells in blood, bone marrow, and the spleen. Liberate Bio applies that delivery capability to in vivo CAR-M (chimeric antigen receptor macrophage) programs, reprogramming monocytes and macrophages to eliminate disease-driving cells without ex vivo manipulation, with programs in hematologic oncology and in autoimmune disease via depletion of pathogenic B-cell populations. Founded by Nessan Bermingham, Theresa M. Reineke, and Michael Mitchell, and led by CEO Shawn Davis and CSO Walter Strapps, the company raised $31M from Khosla Ventures in October 2025. It is pre-clinical and publishes no public API or developer surface.

## Kin Score — 4.1 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 4.1).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Liberatebio Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotechnology, Genetic Medicine, Cell Therapy, Oncology, Autoimmune Disease, Drug Discovery, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/liberatebio/). Scores are computed from the provider's own public artifacts under a published rubric.